First human test for liver disease drug begins
NCT ID NCT02612662
Summary
This was the first study in humans for a potential new drug called AZD4076, which is being developed for a serious liver disease called NASH. The main goal was to check if single, increasing doses were safe and to see how the body processes the drug. It involved 40 healthy male volunteers who received either the drug or a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC STEATOHEPATITIS (NASH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Brooklyn, Maryland, 21225, United States
Conditions
Explore the condition pages connected to this study.